Awareness campaign shows signs of delaying onset of drug-resistant gonorrhea in UK

April 14, 2014

In 2012, there were over 25,000 cases of gonorrhoea in the UK making it the second most common bacterial sexually transmitted infection after chlamydia. Control of gonorrhoea is dependent on successful antibiotic treatment, as the bacterium that causes the infection, Neisseria gonorrhoeae, has become increasingly resistance to every antibiotic used to treat it over the last 60 years. Today, at the Society for General Microbiology's Annual Conference in Liverpool, Professor Cathy Ison explains the challenges facing the treatment of the disease, which threatens to become resistant to all antibiotics.

In 2012, Professor Ison led on the launch of the Health Protection Agency's first Gonorrhoea Resistance Action Plan for England and Wales, as part of the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) that provides on levels of . GRASP, which has provide surveillance data in England and Wales since 2000, has been used to change clinical practice in the UK.

Today, she will show that campaigns in the UK to raise awareness of drug among healthcare professionals, policy-makers and at risk groups have shown some success in delaying the onset of treatment failure to the oral antibiotic cefixime. When evidence of antibiotic-resistance to cefixime was identified it was replaced as treatment of choice by ceftriaxone, an injectable antibiotic of the same class. This was done to prevent the widespread emergence of cefixime-resistance gonorrhoea. Cefixime and ceftriaxone are the last group of antibiotics known to be fully effective against gonorrhoea.

Professor Ison said: "While we have shown that a proactive approach to changing therapy has shown some success, we should remember that this infection has repeatedly become resistant to successive antibiotics over decades, and that it is likely that this is only a temporary reprieve. This will give the internationally community time to investigate new drugs and alternative strategies for treating gonorrhoea and maintain it as a treatable infection."

However, Professor Ison stresses that we should remain vigilant: "We can already see in data from England and Wales, as well as other some countries, that there is the beginning of drifts towards resistance to the injectable drug, ceftriaxone, which is currently used as the drug of choice for gonorrhoea. Public health control of gonorrhoea must include prompt diagnosis, delivery of effective treatment and detection of treatment failures, combined with strong prevention messages."

To combat the continuing high rates of STI transmission in England, and the growing risk of treatment failure it is essential that individuals:

  • Always use a condom when having sex with new and casual partners
  • Reduce the number of sexual partners and avoid overlapping sexual relationships
  • Get a regular STI check-up if having unprotected sex with new or casual partners.

Explore further: Signs of success in delaying onset of drug-resistant gonorrhoea in UK

More information: The Society for General Microbiology's Annual Conference 2014 takes place 14-17 April Arena and Convention Centre, Liverpool, UK.

Related Stories

Signs of success in delaying onset of drug-resistant gonorrhoea in UK

April 11, 2014
Gonorrhoea threatens to become resistant to all of the antibiotics used to treat it. Today, Professor Cathy Ison will explain that campaigns in the UK to raise awareness of drug resistance among healthcare professionals, ...

Last-line antibiotics increasingly ineffective against gonorrhea

June 10, 2013
The last remaining antibiotics used to treat gonorrhea (cefixime and ceftriaxone) in England and Wales are becoming less effective. But recent changes in prescribing practice, based on new recommendations that challenge previous ...

Researchers develop new methods to keep resistant gonorrhoea in check

March 11, 2014
(Medical Xpress)—A pandemic of super-resistant gonorrhoea could be kept in check using new methods to track outbreaks of the disease, according to a University of Queensland infectious diseases expert.

STIs and risky sex still an issue

November 26, 2013
New results from the third National Survey of Sexual Attitudes and Lifestyles (Natsal), published in The Lancet, provide a picture of sexually transmitted infection (STI) prevalence and testing, uptake of sexual health interventions ...

Is there a way to slow the process of bacterial antibiotic resistance?

April 10, 2014
Continually under attack by noxious substances in their environments, bacteria have developed many clever mechanisms to survive. When confronted with an antibiotic, they can destroy it with enzymes, rendering it harmless. ...

Recommended for you

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Mind-body therapies immediately reduce unmanageable pain in hospital patients

July 25, 2017
Mindfulness training and hypnotic suggestion significantly reduced acute pain experienced by hospital patients, according to a new study published in the Journal of General Internal Medicine.

Research examines lung cell turnover as risk factor and target for treatment of influenza pneumonia

July 24, 2017
Influenza is a recurring global health threat that, according to the World Health Organization, is responsible for as many as 500,000 deaths every year, most due to influenza pneumonia, or viral pneumonia. Infection with ...

Scientists propose novel therapy to lessen risk of obesity-linked disease

July 24, 2017
With obesity related illnesses a global pandemic, researchers propose in the Journal of Clinical Investigation using a blood thinner to target molecular drivers of chronic metabolic inflammation in people eating high-fat ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.